Full metadata record
DC FieldValueLanguage
dc.contributor.authorPERRIN JUSTINEen_GB
dc.contributor.authorCAPITAO MARISAen_GB
dc.contributor.authorGOUARD S.en_GB
dc.contributor.authorSAÏ-MAUREL Cen_GB
dc.contributor.authorLOUVET CEDRICen_GB
dc.contributor.authorLANCIEN Men_GB
dc.contributor.authorBRUCHERTSEIFER FRANKen_GB
dc.contributor.authorMORGENSTERN ALFREDen_GB
dc.contributor.authorCHEREL M.en_GB
dc.contributor.authorGASCHET Jen_GB
dc.contributor.authorGUILLOUX YANNICKen_GB
dc.date.accessioned2020-10-16T00:03:14Z-
dc.date.available2020-10-15en_GB
dc.date.available2020-10-16T00:03:14Z-
dc.date.created2020-10-15en_GB
dc.date.issued2020en_GB
dc.date.submitted2020-07-10en_GB
dc.identifier.citationEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING vol. 47 no. S1 p. S159 - S160en_GB
dc.identifier.issn1619-7070 (online)en_GB
dc.identifier.urihttps://publications.jrc.ec.europa.eu/repository/handle/JRC121369-
dc.description.abstractActual cancer therapies are facing numerous challenges towards tumor cell destruction : tumor microenvironment involves immunoregulatory cells and cytokines, which prevent anti-tumoral immune response. Therapeutic combination could be the key to turn these « cold » tumor microenvironment into « hot » ones : more vascularised and infiltrated with immune cells. To this end, this project focus on combining targeted alpha-therapy (TAT) and adoptive T-cells transfer (ACT).en_GB
dc.description.sponsorshipJRC.G.I.5-Advanced Nuclear Knowledgeen_GB
dc.format.mediumOnlineen_GB
dc.languageENGen_GB
dc.publisherSPRINGERen_GB
dc.relation.ispartofseriesJRC121369en_GB
dc.titleReversing cold tumor microenvironment with targeted alpha-therapyen_GB
dc.typeArticles in periodicals and booksen_GB
dc.identifier.doi10.1007/s00259-020-04988-4 (online)en_GB
JRC Directorate:Nuclear Safety and Security

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.